Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ivosidenib has interactions with a variety of drugs, which may affect its effica···【more】
Release date：2026-01-04Recommended：62
Ivosidenib is indicated only for patients with acute myeloid leukemia (AML), cho···【more】
Release date：2025-12-31Recommended：102
Some side effects usually do not require medical treatment and may resolve on th···【more】
Release date：2025-12-31Recommended：84
Ivosidenib is also indicated for the treatment of myelodysplastic syndromes (MDS···【more】
Release date：2025-12-31Recommended：88
On December 26, 2017, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leading comp···【more】
Release date：2025-12-31Recommended：117
The approval of ivosidenib for its indicated uses by the U.S. Food and Drug Admi···【more】
Release date：2025-12-31Recommended：80
The dosage of Ivosidenib may vary among different patients.What is the recommend···【more】
Release date：2025-12-31Recommended：67
Ivosidenib is also indicated for the treatment of previously treated cholangioca···【more】
Release date：2025-12-31Recommended：64
Ivosidenib is the first approved drug of the IDH1 inhibitor class. It works by i···【more】
Release date：2025-12-31Recommended：85
Ivosidenib targets a specific gene mutation called IDH1, which may affect your b···【more】
Release date：2025-12-31Recommended：60
Ivosidenib can be used for the treatment of relapsed or refractory acute myeloid···【more】
Release date：2025-12-31Recommended：66
Ivosidenib, either as a monotherapy or in combination with azacitidine, is indic···【more】
Release date：2025-12-31Recommended：89
